BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31941586)

  • 1. Propensity score-matched analysis of clinical outcome after enucleation versus regular pancreatectomy in patients with small non-functional pancreatic neuroendocrine tumors.
    Weilin M; Xu H; Yang L; Wenqi C; Huanyu W; Wentao Z; Dayong J; Wenchuan W; Dansong W; Tiantao K; Lei Z; Wenhui L; Xuefeng X
    Pancreatology; 2020 Mar; 20(2):169-176. PubMed ID: 31941586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical outcomes between enucleation and regular pancreatectomy in patients with non-functional pancreatic neuroendocrine tumors: a retrospective multicenter and propensity score-matched study.
    Yang Z; Gao H; Lu J; Niu Z; Zhu H; Zong Y; Song X; Yang F; Zhou X
    Jpn J Clin Oncol; 2021 Apr; 51(4):595-603. PubMed ID: 33395471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity score-matched analysis of robotic versus open surgical enucleation for small pancreatic neuroendocrine tumours.
    Tian F; Hong XF; Wu WM; Han XL; Wang MY; Cong L; Dai MH; Liao Q; Zhang TP; Zhao YP
    Br J Surg; 2016 Sep; 103(10):1358-64. PubMed ID: 27480993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally Invasive Versus Open Pancreatectomy for Right-Sided and Left-Sided G1/G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Multicenter Matched Analysis with an Inverse Probability of Treatment-Weighting Method.
    Hwang HK; Song KB; Park M; Kwon W; Jang JY; Heo JS; Choi DW; Kang CM; Park JS; Hong TH; Cho CK; Ahn KS; Lee H; Lee SE; Jeong CY; Roh YH; Kim HJ; Hwang DW; Kim SC; Han HS; Yoon YS;
    Ann Surg Oncol; 2021 Nov; 28(12):7742-7758. PubMed ID: 33969463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
    Chen J; Yang Y; Liu Y; Kan H
    World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
    Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
    World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
    Cienfuegos JA; Salguero J; Núñez-Córdoba JM; Ruiz-Canela M; Benito A; Ocaña S; Zozaya G; Martí-Cruchaga P; Pardo F; Hernández-Lizoáin JL; Rotellar F
    Surg Endosc; 2017 Oct; 31(10):3847-3857. PubMed ID: 28127714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group.
    Sahara K; Tsilimigras DI; Moro A; Mehta R; Dillhoff M; Heidsma CM; Lopez-Aguiar AG; Maithel SK; Rocha FG; Kanji Z; Abbott DE; Fisher A; Fields RC; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho CS; Beems M; Endo I; Pawlik TM
    Neuroendocrinology; 2021; 111(1-2):129-138. PubMed ID: 32040951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Outcomes of Enucleation and Standard Resections in Patients with a Pancreatic Neuroendocrine Tumor.
    Jilesen AP; van Eijck CH; Busch OR; van Gulik TM; Gouma DJ; van Dijkum EJ
    World J Surg; 2016 Mar; 40(3):715-28. PubMed ID: 26608956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort.
    Bolm L; Nebbia M; Wei AC; Zureikat AH; Fernández-Del Castillo C; Zheng J; Pulvirenti A; Javed AA; Sekigami Y; Petruch N; Qadan M; Lillemoe KD; He J; Ferrone CR;
    Ann Surg; 2022 Sep; 276(3):522-531. PubMed ID: 35758433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.
    Ge W; Zhou D; Xu S; Wang W; Zheng S
    Int J Surg; 2017 Mar; 39():127-134. PubMed ID: 28137555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score matching study.
    Chen K; Tong Q; Yan JF; Huang CJ; Pan Y; Zhang RC; Chen QL; Zheng XY; Cai XY; Wang Y; Wang XF
    Updates Surg; 2020 Jun; 72(2):387-397. PubMed ID: 32266660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
    Zhou B; Zhan C; Xiang J; Ding Y; Yan S
    BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term and long-term outcomes after robot-assisted versus laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs): a multicenter comparative study.
    Alfieri S; Butturini G; Boggi U; Pietrabissa A; Morelli L; Vistoli F; Damoli I; Peri A; Fiorillo C; Pugliese L; Ramera M; De Lio N; Di Franco G; Esposito A; Landoni L; Rosa F; Menghi R; Doglietto GB; Quero G;
    Langenbecks Arch Surg; 2019 Jun; 404(4):459-468. PubMed ID: 31055639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
    Kazanjian KK; Reber HA; Hines OJ
    Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of minimal invasive surgical treatment for pancreatic neuroendocrine tumors].
    Zhu QC; Jin WW; Mou YP; Zhou YC; Wang YY; Xia T; Lu C
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2854-2857. PubMed ID: 32988146
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors.
    Toyoda J; Sahara K; Tsilimigras DI; Miyake K; Yabushita Y; Homma Y; Kumamoto T; Matsuyama R; Pawlik TM
    World J Surg; 2021 Dec; 45(12):3643-3651. PubMed ID: 34379172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study.
    Han SH; Han IW; Heo JS; Choi SH; Choi DW; Han S; You YH
    Surg Endosc; 2018 Jan; 32(1):443-449. PubMed ID: 28664429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients.
    Zheng J; Pulvirenti A; Javed AA; Michelakos T; Paniccia A; Lee KK; Ferrone CR; Wei AC; He J; Zureikat AH;
    J Am Coll Surg; 2022 Aug; 235(2):315-330. PubMed ID: 35839409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.